Antibody-drug conjugates and uses thereof
US-2015366988-A1 · Dec 24, 2015 · US
US9895556B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9895556-B2 |
| Application number | US-201314413561-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 19, 2013 |
| Priority date | Jul 25, 2012 |
| Publication date | Feb 20, 2018 |
| Grant date | Feb 20, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A system and method include a shape sensing enabled device ( 116 ) having at least one optical fiber ( 118 ). A source positioning module ( 124 ) is configured to receive optical signals from the at least one optical fiber within a structure and interpret the optical signals to provide motion information of treatment sources within the device. A dose determination module ( 130 ) is configured to provide one or more temporal bins representing a total treatment time. For each temporal bin, the dose determination module is configured to determine a dose received by a target area to be treated using the motion information of the treatment sources. The dose determination module is further configured to combine the dose received by the target area for each of the one or more temporal bins to determine a total dose received by the target area.
Opening claim text (preview).
The invention claimed is: 1. A system, comprising: a shape sensing enabled device comprising at least one optical fiber; a source positioning module configured to receive optical signals from the at least one optical fiber and interpret the optical signals to provide motion information of the shape sensing enabled device, the motion information comprising a shape and a position of the shape sensing enabled device and a position of treatment sources within the shape sensing enabled device at any time during treatment; and a dose determination module configured to provide one or more temporal bins cumulatively equaling a total treatment time, wherein for each temporal bin, the dose determination module is configured to determine a dose received by a target area to be treated using the motion information of the shape sensing enabled device, the dose determination module further configured to combine the dose received by the target area for each of the one or more temporal bins to determine a total dose received by the target area. 2. The system as recited in claim 1 , wherein the dose determination module is configured to determine a dose delivered by the treatment sources using the motion information of the treatment sources. 3. The system as recited in claim 1 , wherein the dose determination module is configured to determine a dose delivered by the treatment sources using an initial treatment plan. 4. The system as recited in claim 2 , wherein the dose determination module is further configured to determine the dose received by the target area as the dose delivered by the treatment sources. 5. The system as recited in claim 2 , further comprising an imaging module configured to provide motion information of the target area by imaging the target area, wherein the imaging module is further configured to produce images comprising voxels. 6. The system as recited in claim 5 , wherein the dose determination module is further configured to create probability distribution functions (PDFs) of motion patterns of each voxel of the target area based upon the motion information of the target area. 7. The system as recited in claim 6 , wherein the dose determination module is further configured to convolve the PDFs of each voxel with the dose delivered by the treatment sources to determine the dose received by the target area. 8. The system as recited in claim 5 , wherein the imaging module is configured to perform at least one of ultrasound or magnetic resonance imaging. 9. The system as recited in claim 1 , wherein the shape sensing enabled device is a catheter. 10. The system as recited in claim 1 , further comprising a planning module configured to modify a treatment plan based upon at least one of the motion information of the treatment sources or motion information of the target area. 11. The system as recited in claim 1 , wherein the total treatment time includes a time for at least one of: a single fraction, multiple fractions, or fractions for a time period. 12. A workstation, comprising: a shape sensing system including: a shape sensing enabled device comprising at least one optical fiber; a source positioning module configured to receive optical signals from the at least one optical fiber and interpret the optical signals to provide motion information of the shape sensing enabled device, the motion information comprising a shape and a position of the shape sensing enabled device and a position of treatment sources within the shape sensing enabled device at any time during treatment; a dose determination module configured to provide one or more temporal bins cumulatively equaling a total treatment time, wherein for each temporal bin, the dose determination module is configured to determine a dose received by a target area to be treated using the motion information of the shape sensing enabled device, the dose determination module further configured to combine the dose received by the target area for each of the one or more temporal bins to determine a total dose received by the target area; and a display. 13. The workstation as recited in claim 12 , wherein the dose determination module is configured to determine a dose delivered by the treatment sources using at least one of the motion information of the treatment sources or an initial treatment plan, and wherein the dose determination module is further configured to determine the dose received by the target area as the dose delivered by the treatment sources. 14. The workstation as recited in claim 13 , further comprising an imaging module configured to provide motion information of the target area by imaging the target area, wherein the imaging module is further configured to produce images comprising voxels, wherein the dose determination module is further configured to create probability distribution functions (PDFs) of motion patterns of each voxel of the target area based upon the motion information of the target area, and wherein the dose determination module is further configured to convolve the PDFs of each voxel with the dose delivered by the treatment sources to determine the dose received by the target area. 15. A method, comprising: determining motion information of a shape sensing enabled device, the motion information comprising a shape and a position of the shape sensing enabled device and a position of treatment sources within the shape sensing enabled device at any time during treatment; providing one or more temporal bins cumulatively equaling a total treatment time; for each of the one or more temporal bins, computing a dose received by a target area to be treated using the motion information of the shape sensing enabled device; and combining the dose received by the target area for each of the one or more temporal bins to determine a total dose received by the target area.
Details of the control system, e.g. user interfaces · CPC title
using radiation sources introduced into or applied onto the body; brachytherapy · CPC title
using functional images, e.g. PET or MRI · CPC title
taking into account movement of the target · CPC title
for adjusting radiation treatment in response to monitoring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.